{"nct_id":"NCT05125302","title":"Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2022-01-13","start_date_type":"ACTUAL","primary_completion_date":"2026-05","primary_completion_date_type":"ESTIMATED","completion_date":"2026-05","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["ABBV"]}